Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02674113

Regional Anesthesia in Hip Arthroscopy

Use of Regional Anesthesia in Hip Arthroscopy

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to determine differences in outcomes in patients who receive regional anesthesia (a fascia iliaca block) versus placebo prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement.

Detailed description

Methods: After informed consent is obtained at a routine/pre-surgical clinic visit, all patients who meet eligibility criteria will undergo randomization into one of two groups. These groups are 1) to receive regional anesthesia (a single shot fascia iliaca block using bupivacaine) prior to hip arthroscopy, or 2) undergo a subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water) instead of bupivacaine. Intra-operatively, both groups will receive general anesthesia and local anesthesia (lidocaine and bupivacaine in the peripheral compartment).

Conditions

Interventions

TypeNameDescription
DRUGregional anesthesia bupivacainea single shot fascia iliaca block using bupivacaine prior to hip arthroscopy
DRUGregional anesthesia placebosubcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water)

Timeline

Start date
2015-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-02-04
Last updated
2017-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02674113. Inclusion in this directory is not an endorsement.